Efthymios Deliargyris Cytosorbents Corp (CTSO) insider trading activity

CTSO Quotes by TradingView

Efthymios Deliargyris is Chief Medical Officer of Cytosorbents Corp. Currently has a direct ownership of 403,025 shares of CTSO, which is worth approximately $463,478. The most recent transaction as insider was on Jan 17, 2025, when has been sold 16,233 shares (Common Stock) at a price of $1.0 per share, resulting in proceeds of $16,233. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 403K
1.57% 3M change
15.67% 12M change
Total Value Held $463,478

Efthymios Deliargyris Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 17 2025
BUY
Exercise of in-the-money or at-the-money derivatives securities
$16,233 $1.0 p/Share
16,233 Added 3.87%
403,025 Common Stock
Apr 02 2024
BUY
Grant, award, or other acquisition
-
61,000 Added 12.97%
409,433 Common Stock
Dec 13 2023
BUY
Open market or private purchase
$30,000 $1.33 p/Share
22,557 Added 6.08%
348,433 Common Stock
Jul 07 2023
BUY
Grant, award, or other acquisition
-
55,000 Added 14.22%
331,648 Common Stock
Aug 10 2022
BUY
Grant, award, or other acquisition
-
107,000 Added 27.41%
283,384 Common Stock
Apr 12 2021
BUY
Grant, award, or other acquisition
$359,600 $8.99 p/Share
40,000 Added 17.94%
183,000 Common Stock
ED

Efthymios Deliargyris

Chief Medical Officer
Princeton, NJ

Track Institutional and Insider Activities on CTSO

Follow Cytosorbents Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTSO shares.

Notify only if

Insider Trading

Get notified when an Cytosorbents Corp insider buys or sells CTSO shares.

Notify only if

News

Receive news related to Cytosorbents Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTSO